Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Incontinence after Prostate Treatment: AUA/GURS/SUFU Guideline (2024)
Using AUA Guidelines
Access to AUA guidelines is provided free for individuals’ clinical use only. Anyone accessing AUA guidelines for any other purpose must obtain a license in advance. Licenses for academic, research and educational purposes can be requested through the AUA by contacting permissions@AUAnet.org.
Licenses for promotional or commercial use can be requested by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on AUA clinical guideline usage and licensing.
By reading this guideline, you agree to AUA's Guidelines Terms and Conditions of Use.
Using AUA Guidelines
Access to, and limited authorized use of AUA guidelines is a member benefit. Members are granted a limited license to access and use the AUA Guidelines for their individual, non-commercial use, for clinical, academic, educational, and research purposes, in accordance with the AUA Guidelines Terms and Conditions of Use. Members who wish to use the Guidelines for any other purpose, or in any manner not authorized by this limited license grant or by the AUA Guidelines Terms and Conditions of Use must request and obtain a license/permission in advance. Licenses for business or institutional academic, research and educational related purposes (e.g., use in course packs or for employer-sponsored research) can be requested through the AUA by contacting permissions@AUAnet.org.
Licenses for promotional or commercial use can be requested by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on AUA clinical guideline usage and licensing.
By reading this guideline, you agree to AUA's Guidelines Terms and Conditions of Use.
Using AUA Guidelines
Access to AUA guidelines is provided free for individual clinical use only, in accordance with the AUA Guidelines Terms and Conditions of Use. Anyone accessing AUA guidelines for any other purpose must obtain a license/permission in advance. Licenses for academic, research and educational purposes (e.g., in course packs or employer-sponsored research) can be requested through the AUA by contacting permissions@AUAnet.org.
Licenses for promotional or commercial use can be requested by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on AUA clinical guideline usage and licensing.
By reading this guideline, you agree to AUA's Guidelines Terms and Conditions of Use.
Using AUA Guidelines
Access to AUA guidelines is provided free for health care providers for their individual clinical use only. Patients and the general public are provided a summary of the guidelines. Patients who wish to discuss the full guidelines should consult with their healthcare provider.
Guideline Resources
Incontinence after Prostate Treatment Guideline PDF
Incontinence after Prostate Treatment Amendment Summary
Incontinence after Prostate Treatment Evaluation Algorithm
Incontinence after Prostate Treatment Surgical Management Algorithm
Incontinence after Prostate Treatment Sling Failure Algorithm
Incontinence after Prostate Treatment AUS Failure Algorithm
(Published 2019, Amended 2024)
Purpose
Incontinence after prostate treatment (IPT) causes emotional and financial distress to patients afflicted with this condition by delaying patients' re-entry into society, inhibiting relationships, and carrying an economic burden for families and stakeholders. It is a condition that has gained visibility not only due to the extensive use of surgery for prostate cancer but also given the proliferation of men's continence products available to the lay public. Given that IPT is caused by treatment of the prostate, it is by definition iatrogenic. As such, it is perhaps preventable or predictable. Understanding the nature of IPT is crucial for patients and clinicians during recovery and extended survivorship following prostate treatment.
Key Takeaways
This Guideline is intended to facilitate care decisions and aid clinicians in the management of patients who have incontinence after undergoing treatment of localized prostate cancer and benign prostatic hyperplasia (BPH). Topics discussed include the following:
- Pre-treatment
- Post-prostate treatment
- Evaluation of IPT
- Treatment options
- Complications after surgery
- Special situations
Create a free account to access expanded content and resources.
AUA Clinical Practice Guidelines are developed by multidisciplinary panels of experts based on rigorous systematic review of current urologic research.
| Free Resources | |
 |
Patient Education Fact Sheet |
| Login to Continue | |
| Member Benefit | |
|
Incontinence after Prostate Treatment Guideline PDF |
|
Incontinence after Prostate Treatment Amendment Summary |
|
Incontinence after Prostate Treatment Evaluation Algorithm |
|
Incontinence after Prostate Treatment Surgical Management Algorithm |
|
Incontinence after Prostate Treatment Sling Failure Algorithm |
|
Incontinence after Prostate Treatment AUS Failure Algorithm |